In the fight against the coronavirus anything goes. And, as we have already told on occasion, the elements to plant in front of it can be found anywhere, either in a medicine for cats or, as we have known today by EurekAlert, in the mouthwash we all use (or should we use) to take care of our oral health. Yes, you read that correctly, that liquid with an intense and persistent flavor, a somewhat suspicious color and that, somehow, concentrates the cold of northern Europe in winter in a single sip.
And it is that researchers from the Penn State College of Medicine have discovered that certain types of mouthwashes, as well as antiseptic nasal and oral rinses, potentially ‘inactivate’ human coronaviruses that have a similar structure to the SARS-CoV-2 virus, pathogens responsible for COVID-19. And we are not talking about a minor effect, some, thanks to their antiseptic function, could inactivate 99.9 percent of the human coronavirus in 30 seconds.
Obviously, this doesn’t change anything when it comes to research to find the coronavirus vaccine. The medicine for cats is, as we already told you at the time, a retroviral, and in this case we are talking about an antiseptic that, like the hydroalcoholic gel that has already become part of our day to day. With the difference that, in the case of mouthwash, if the results of the study are confirmed, we could be talking about a means to stop the spread of the pathogen to some extent.
Why? We only have to look at our faces, whenever we are on the street, to understand why. I mean, of course, the mask, and as we already know, both the nose and the mouth are important sources of transmission and entry of the coronavirus in humans. This is why many healthcare professionals have started using a 1 percent baby shampoo solution to rinse their sinuses, as this inactivates more than 99.9 percent of the human coronavirus after two minutes.
The possibility that a common hygiene product could become another brake on the spread of the coronavirus is, in principle, excellent news, since access to it is widespread and, therefore, its use could spread rapidly. However, we must remember that at the moment we are talking about a single test, a clinical study should be the next step to determine if these solutions effectively reduce viral load in COVID-19 patients specifically.
You can find the paper of this research here.